ArticleWorld journal of gastrointestinal oncology2024

Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma.

Feng Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.